{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:48:11Z","timestamp":1786636091863,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0973-1482.73332","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T05:13:02Z","timestamp":1291007582000},"page":"313","source":"Crossref","is-referenced-by-count":24,"title":["Crystalline maculopathy: A rare complication of tamoxifen therapy"],"prefix":"10.4103","volume":"6","author":[{"given":"Nirmala","family":"Srikantia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mukesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.73332-1","first-page":"1371","volume-title":"Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0973-1482.73332-2","unstructured":"Rugo HS. Cancer. In: Mcphee SJ, Papadakis MA, Tierney LM, editors. Current medical diagnosis and treatment. 3 rd ed. USA: Hill companies; 2007. p. 1670-730."},{"key":"key-10.4103\/0973-1482.73332-3","first-page":"505","volume-title":"Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: Results from International Breast Cancer Study Group trials","author":"Gianni","year":"2006","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.73332-4","first-page":"315","volume-title":"Tamoxifen retinopathy","author":"Kaiser-Kupfer","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"key-10.4103\/0973-1482.73332-5","first-page":"1018","volume-title":"Tamoxifen associated eye disease: A review","author":"Nayfield","year":"1996","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.73332-6","first-page":"126","volume-title":"Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy","author":"Bourla","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0973-1482.73332-7","first-page":"544","volume-title":"Tamoxifen retinopathy: A case series of clinical and functional data","author":"Ritter","year":"2008","journal-title":"Ophthalmologe"},{"key":"key-10.4103\/0973-1482.73332-8","first-page":"89","volume-title":"Tamoxifen retinopathy: A clinicopathologic report","author":"Kaiser-Kupfer","year":"1981","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0973-1482.73332-9","first-page":"138","volume-title":"Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses","author":"Lullmann","year":"1981","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:53:42Z","timestamp":1786632822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.73332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["73332"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.73332","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}